Skip to content
Alltrna
A Flagship Pioneering Company
Science Platform Team Press Contact | Job Listings

Partnerships

partnerships@alltrna.com

Careers

careers@alltrna.com

Press

press@alltrna.com
LinkedIn Twitter

IN THE PRESS

Press Releases, Resources, and Media Coverage,

Press Releases

Read all Press Releases
  1. Alltrna Expands Leadership Team with Appointments of Chief Scientific Officer and Chief Technology Officer

    15 Aug 2023
  2. Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease

    09 Aug 2023
  3. Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons

    18 May 2023
  4. Alltrna Appoints Caroline Kӧhrer, Ph.D., Vice President, Discovery Platform

    17 Oct 2022
  5. Alltrna Expands Leadership Team with Appointment of Joanne Protano as Chief Financial Officer

    02 Aug 2022

Resources

  1. JBC Review Article: Ushering in the era of tRNA medicines

    11 Sep 2023
  2. Defining Stop Codon Disease to Unify Treatment for Thousands of Conditions

    10 Aug 2023

Media Coverage

Read all Media Coverage
  1. PharmaVoice 100 Stand-out Execs: Michelle Werner

    19 Sep 2023
  2. In Vivo: Exploring Alltrna’s Rare Disease Platform

    14 Sep 2023
  3. The Scientist: The Origins and Recent Promise of Nonsense Suppressor tRNAs

    06 Sep 2023
  4. MedCity News: Alltrna Unveils $109M to Make tRNA a Universal Therapy for Genetic Diseases

    09 Aug 2023
  5. Endpoints: Flagship startup Alltrna raises $109M for tRNA therapies that restore missing proteins

    09 Aug 2023
Alltrna A Flagship Pioneering Company
Accessibility Statement
© Copyright 2023 Alltrna